Fate Therapeutics

Fate Therapeutics Liabilities

The The Liabilities of Fate Therapeutics (FATE) as of Oct 24, 2026 is 111.75 M USD. In the previous year, The Liabilities was 121.97 M USD — a change of -8.38% (lower).

Liabilities

111.75 MUSD

YoY

-8.38%

Last updated:

In 2025, Fate Therapeutics's total liabilities amounted to 111.75 M USD, a -8.38% difference from the 121.97 M USD total liabilities in the previous year.

The Fate Therapeutics Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2018
52.56 M USD
Jan 1, 2019
57.52 M USD
Jan 1, 2020
238.01 M USD
Jan 1, 2021
242.62 M USD
Jan 1, 2022
221.62 M USD
Jan 1, 2023
137.80 M USD
Jan 1, 2024
121.97 M USD
Jan 1, 2025
111.75 M USD
The Fate Therapeutics Liabilities history
YEARLiabilitiesYoY
111.75 MUSD-8.38%
121.97 MUSD-11.49%
137.80 MUSD-37.82%
221.62 MUSD-8.65%
242.62 MUSD+1.93%
238.01 MUSD+313.80%
57.52 MUSD+9.43%
52.56 MUSD+87.04%
28.10 MUSD+28.36%
21.89 MUSD-26.82%
29.92 MUSD+30.86%
22.86 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Fate Therapeutics Stock analysis

What does Fate Therapeutics do? Fate Therapeutics Inc is a biotechnology company specializing in the development of cell therapies. The company was founded in 2007 by four scientists who recognized the need for new therapies and treatment options. Their goal was to find new ways to promote tissue and organ regeneration and repair by harnessing the biological mechanisms within cells. Fate Therapeutics' business model is to develop and market state-of-the-art cell therapies based on human stem cells. These stem cells are typically obtained from patients' bone marrow or adipose tissue and then cultured in specialized cell cultures to prepare them for medical use. Fate Therapeutics currently offers several different products and services, including: - Cell therapies for the treatment of cancer: The company has developed a range of cell therapies aimed at boosting the immune system and mobilizing against cancer cells. These therapies are based on the method of extracting so-called T cells from the patient's blood, growing and modifying them in the lab to enhance their ability to target cancer cells. - Therapies for the treatment of genetic diseases: Fate Therapeutics has also developed cell therapies aimed at treating genetic mutations or defects. These therapies are based on the method of obtaining pluripotent stem cells (iPS cells) from the patient's blood or adipose tissue and then differentiating them into specialized cell types that can be used to repair tissue damage or correct genetic defects. - Services to support research and development: Fate Therapeutics also offers services to assist researchers in developing and testing their own cell therapies. This includes the cell cultures, devices, and assays needed to generate and analyze new cell lines. Fate Therapeutics is divided into several divisions to better manage its various business areas. These divisions include: - Research & Development: This division is responsible for conducting basic research to develop and test new cell therapies. This includes both foundational research and the clinical trials necessary to evaluate the effectiveness and safety of new therapies. - Manufacturing: This division is responsible for the large-scale production and processing of Fate Therapeutics' cell therapies. The company has multiple production facilities in the United States and internationally to ensure swift and efficient manufacturing and delivery of its therapies. - Sales & Marketing: This division is responsible for marketing and selling Fate Therapeutics' cell therapies. The company works closely with doctors, clinics, and medical facilities to ensure that therapies reach the patients who need them. Overall, Fate Therapeutics has become a global leader in the development of cell therapies. The company has made significant progress in recent years in developing new therapies and continues to work on finding innovative solutions to medical challenges. With its competent leadership and top-notch products and services, Fate Therapeutics Inc. is poised for even greater success in the future. Fate Therapeutics is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Fate Therapeutics's Liabilities

Fate Therapeutics's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Fate Therapeutics's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Fate Therapeutics's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Fate Therapeutics's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Fate Therapeutics’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Fate Therapeutics stock

The Liabilities of Fate Therapeutics is 111.75 M USD in 2025.

The Liabilities of Fate Therapeutics changed from 121.97 M USD to 111.75 M USD, representing a -8.38% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Fate Therapeutics since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Fate Therapeutics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Fate Therapeutics

All Key Metrics — Fate Therapeutics